Review Article
Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review
Table 2
Quality assessment based on the JBI tool for case reports.
| | Giuliana Galassi et al. | Myung Ah Lee et al. | Augustine Chavez et al. |
| 1. Were the patient’s demographic characteristics clearly described? | Yes | Yes | Yes | 2. Was the patient’s history clearly described and presented as a timeline? | Yes | Not clear | Yes | 3. Was the current clinical condition of the patient on presentation clearly described? | Yes | Yes | Yes | 4.Were diagnostic tests or assessment methods and the results clearly described? | Yes | Yes | Yes | 5. Was the intervention (s) or treatment procedure (s) clearly described? | Yes | Yes | Not clear | 6. Was the postintervention clinical condition clearly described? | Yes | Yes | Yes | 7. Were adverse events (harms) or unanticipated events identified and described? | Yes | Yes | Yes | 8. Does the case report provide takeaway lessons? | Yes | Yes | Yes |
|
|